Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT02441608 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2015-11-10
Summary
The purpose of this study is to prove the product tested does not cause photoirritation or photosensitization reactions when exposed to sun light.
Conditions
- Skin Irritability
- Skin Sensitization
Interventions
- DEVICE
-
KL029 Intimate Lubricant Gel
All the volunteers will receive the application of four dressings (3 placebos and 1 containing the tested product). After a certain period of time, photoirritation and photosensitization will be measured through the evaluation of tested region.
Sponsors & Collaborators
-
Kley Hertz S/A
lead INDUSTRY
Study Design
- Allocation
- NA
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2015-06-30
- Completion
- 2015-07-31
More Related Trials
-
Xerotic Dermatitis in Aged People
NCT01806935 ·Status: COMPLETED ·Phase: NA
-
Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery
NCT03231813 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 ·Status: COMPLETED ·Phase: PHASE1
-
Skin Irritation Test of Ten Products
NCT05245383 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin
NCT03640832 ·Status: COMPLETED ·Phase: NA
-
Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.
NCT04332445 ·Status: COMPLETED ·Phase: NA
-
21 Day Cumulative Skin Irritation of RUT058-60
NCT02198963 ·Status: COMPLETED ·Phase: PHASE1
-
18348-Human Phototoxicity Test
NCT02823483 ·Status: COMPLETED ·Phase: NA
-
Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners
NCT03483025 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test
NCT01892657 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Cicaplast in Subjects With Skin Irritation
NCT05767333 ·Status: COMPLETED
-
Efficacy of Dexpanthenol in Thermic Erythema
NCT00839462 ·Status: COMPLETED ·Phase: PHASE2
-
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30
NCT01887808 ·Status: COMPLETED ·Phase: NA
-
Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging
NCT02787356 ·Status: WITHDRAWN ·Phase: NA
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
NCT00646867 ·Status: COMPLETED ·Phase: NA
-
To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects
NCT07109453 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion
NCT01892423 ·Status: COMPLETED ·Phase: NA
-
Epicutaneous Testing of Cosmetics for Skin Compatibility
NCT03024671 ·Status: RECRUITING ·Phase: NA
-
To Check Dermatological Safety of Test Products by 24 Hours Patch Test on Adult Healthy Human Subjects.
NCT06631898 ·Status: COMPLETED ·Phase: NA
-
Human Photoallergy Test (824/2016)
NCT02962869 ·Status: COMPLETED ·Phase: NA
-
To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products
NCT04007159 ·Status: COMPLETED ·Phase: NA
-
To Test for Photo Allergy Reaction of Sunscreens
NCT02872220 ·Status: COMPLETED ·Phase: NA
-
Moisturizing Effect of Two Dexpanthenol Formulations
NCT00839280 ·Status: COMPLETED ·Phase: PHASE2